Spring Bank Pharmaceuticals, Inc. — Form D/A
Spring Bank Pharmaceuticals, Inc. of HOPKINTON, MA, a company, filed a Form D amendment with the SEC on 2015-02-27. The offering totals $21.6M, of which $21.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-02-27
- Form: D/A
- Accession: 0001566373-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $21.6M
- Amount sold: $21.6M
- Investors: 72
- Date of first sale: 2014-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-232149
Issuer
- Name: Spring Bank Pharmaceuticals, Inc.
- CIK: 0001566373
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 86 SOUTH STREET, HOPKINTON, MA, 01748
- Phone: 508-473-5993
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| David Ellsworth Arkowitz | Director | Milford, MA |
| Jonathan Ellsworth Bates | Director | Milford, MA |
| Radhakrishnan Parameswaran Iyer | Director | Milford, MA |
| Douglas John Jensen | Director | Milford, MA |
| Guy Parameswaran Macdonald | Director | Milford, MA |
| Radhakrishnan Parameswaran Iyer | Executive Officer | Milford, MA |
| Douglas John Jensen | Executive Officer | Milford, MA |
| Martin Driscoll | Director | Southlake, TX |
| Martin Driscoll | Executive Officer | Southlake, TX |
| Jonathan Kris Bates | Director | Hopkinton, MA |
| R.P. Kris Iyer | Director | Hopkinton, MA |
| David Kris Arkowitz | Director | Hopkinton, MA |
| Nezam Afdhal | Executive Officer | Hopkinton, MA |
| Jonathan Freve | Executive Officer | Hopkinton, MA |
| Michael Francis Cronin | Executive Officer | Milford, MA |
| Guy Francis Macdonald | Director | Milford, MA |
| Donald Moore Mitchell | Executive Officer | Milford, MA |
| Nezam Ellsworth Afdhal | Executive Officer | Milford, MA |
| Gregg Ellsworth Beloff | Executive Officer | Milford, MA |
| Jonathon Ellsworth Bates | Director | Milford, MA |
| Kurt M Eichler | Director | Marietta, GA |
Other filings by this issuer (4)
More